160 Health International Limited (HKG:2656)

160 Health International Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar 4, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-1.23	-1.24	-0.80	-0.09
Net Debt / Equity Ratio	-0.55	-0.58	0.61	0.01
Net Debt / EBITDA Ratio	-1.39	-0.51	0.26	0.04
Net Debt / FCF Ratio	-2.40	-0.90	0.37	0.05
Asset Turnover	-	2.33	3.03	-
Inventory Turnover	-	74.71	42.09	-
Quick Ratio	0.62	0.63	0.70	0.19
Current Ratio	0.73	0.74	0.81	0.29
Return on Assets (ROA)	-	-24.57%	-29.74%	-
Return on Capital Employed (ROCE)	45.20%	142.80%	578.20%	18.20%
Buyback Yield / Dilution	-2.91%	-1.18%	-1.71%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.